Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic doxazosin to reduce urinary retention after lower extremity arthroplasty
ChiCTR2200056992Phase 4Recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in postoperative urinary retention (POUR), postoperative pain, surgical site infection (SSI) and 1 more comparing Doxazosin group with Placebo group (2 arms). Primary endpoint: Postoperative urinary retention. Started Feb 2022; status: recruiting.
02
Drugs
doxazosin
03
Conditions
postoperative urinary retention (POUR)postoperative painsurgical site infection (SSI)Micturition disorder
Beyond the preview
Go deeper on ChiCTR2200056992.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200056992.